Brown Capital Management, an investment management company, released its fourth quarter 2025 investor letter for “The Brown Capital Management Small Company Fund”. A copy of the letter can be ...

Interventional glaucoma treatment with trabecular micro-bypass stent implantation significantly reduces medication burden, which is associated with improved signs and symptoms of ocular surface ...

Next-generation vascular stents can make cardiovascular therapies minimally invasive and vascular treatments safe and less burdensome. In a new advancement, researchers from Japan and China have ...

Boston Scientific has issued a recall letter to users of the Axios stent after FDA linked the device to three deaths and 167 serious injuries. The deaths were linked to use cases of the stent that ...

Researchers have identified a metabolically sensitive cell subtype in the eye's drainage system which shows early signs of dysfunction in a genetic mouse model of glaucoma. The study, published in ...

Bausch + Lomb has partnered with the glaucoma community once again, launching its fifth annual fundraising challenge and sponsoring an awareness campaign in one of its priority therapeutic areas.

In a nationwide study of about 0.16 million individuals receiving second-generation drug-eluting stents, having type 1 diabetes was linked to a substantially higher risk for stent failure than not ...

You may notice vision loss and changing glaucoma symptoms if your prescribed medicated eye drops stop working. Your doctor can help test your visual field and determine if you need different drops or ...

You can experience eyestrain and glaucoma at the same time. They aren’t directly related, but certain factors of each eye condition can affect the symptoms of both. While glaucoma and eyestrain are ...